Justification and Approval for Sole Source TPOXX Requirement
JA-21-Edg-645
The purpose of this sole source award to Siga Tecnologies Inc., is to replenish existing National Stock Pile quantities of TPOXX, an oral Small Pox Treatment capsule, approved by the US FDA in 2018.